Safety processes and regulations apply to custom-made medicines, which differ from traditional pharmacies. Now, however, ...

Barclays analyst Peter Lawson has reiterated their neutral stance on BMEA stock, giving a Hold rating yesterday. Peter Lawson has given his ...

Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...

According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1 – which is what ...

In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst embarked on ...

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where Viking ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

New research suggests GLP-1 medications can blunt people's cravings for potentially addictive substances like opioids.

To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...

Vivani Medical today announced that Australian authorities approved a first-in-human clinical trial for its subdermal GLP-1 ...